(CercleFinance.com) – Implanet shares soar this Thursday on the Paris Stock Exchange, following the announcement by the orthopedic surgery specialist of a fundraising project which seems to reassure the market.
The stock, which opened lower this morning, is currently climbing more than 46% after briefly posting a gain of 87%. At the same time, the CAC Small lost around 0.5%.
The manufacturer of implants and technological medical equipment has concluded an agreement with the Chinese group Sanyou Medical, its reference shareholder, for the latter to participate in a capital increase of five million euros.
Implanet explains that it is considering, in total, the launch in January 2024 of a fundraising operation with maintenance of preferential subscription rights (DPS) for an amount of between 5.5 and 6.4 million euros.
This announcement comes at a time when the company only had a cash position of around 300,000 euros at the end of August.
During the first half of 2023, its turnover stood at 4.27 million euros, a slight increase of 4% compared to the first half of 2022.
The company, which managed to control its operating expenses, reduced its current operating loss to 2.1 million euros in the first half, compared to -2.2 million a year earlier.